Related Experiment Video
Updated: Sep 14, 2025
08:16
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
7.5K
BLIMP1 negatively regulates IL-2 signaling in T cells
Suyasha Roy1, Min Ren1, Peng Li1
1Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Science Advances
|July 18, 2025
Summary
B lymphocyte-induced maturation protein 1 (BLIMP1) inhibits Interleukin-2 (IL-2) signaling. BLIMP1 deficiency enhances IL-2 signaling in T cells, suggesting BLIMP1 as a potential therapeutic target for immune regulation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Interleukin-2 (IL-2) is critical for immune homeostasis, balancing effector and regulatory T (Treg) cells.
- The regulators of IL-2 signaling are not fully understood.
- B lymphocyte-induced maturation protein 1 (BLIMP1) is known to inhibit IL-2 production but its role in IL-2 signaling is unclear.
Purpose of the Study:
- To identify novel regulators of IL-2 signaling.
- To elucidate the role of BLIMP1 in IL-2 signaling pathways.
- To investigate BLIMP1's function in both normal and pathological immune responses.
Main Methods:
- Genome-wide CRISPR-knockout screening in IL-2-dependent adult T cell leukemia (ATL) cells.
- Overexpression and knockout studies of the PRDM1 gene (encoding BLIMP1) in mouse and human CD4+ T cells and Treg cells.
- Analysis of IL-2 signaling in T cells from mouse models of influenza infection and colitis, and from ATL patients.
Main Results:
- CRISPR screening identified PRDM1 as a regulator of IL-2 signaling.
- Overexpression of PRDM1 down-regulated IL-2 signaling, while PRDM1 deficiency enhanced it.
- Enhanced IL-2 signaling was observed in BLIMP1-deficient T cells, T cells from infected mice, and during colitis.
- ATL patient T cells showed reduced BLIMP1 and heightened IL-2 signaling, which was suppressed by PRDM1 overexpression.
Conclusions:
- BLIMP1 acts as an inhibitor of IL-2 signaling in T cells.
- BLIMP1's role in inhibiting IL-2 signaling is relevant in both physiological and pathological conditions, including ATL.
- Targeting BLIMP1 may offer a therapeutic strategy for modulating IL-2 signaling and immune responses.
Related Concept Videos
01:24T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K